Literature DB >> 18214177

Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States.

Stuart L Nightingale1, Joanna M Prasher, Stewart Simonson.   

Abstract

The US Emergency Use Authorization (EUA) is a critical new tool for medical and public health communities and is applicable for both civilian and military use. It fills the need for timely and practical medical treatment under emergency conditions and authorizes use of the best product available for treatment or prevention when the relevant product has not already been approved or approved for this specific use by the US Food and Drug Administration. The need for and genesis of the EUA, its requirements, its broad application to civilian and military populations, and its features of particular importance to physicians and public health officials are detailed.

Mesh:

Year:  2007        PMID: 18214177     DOI: 10.3201/eid1307.061188

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  12 in total

1.  The anthrax vaccine and research: reactions from postal workers and public health professionals.

Authors:  Sandra Crouse Quinn; Tammy Thomas; Supriya Kumar
Journal:  Biosecur Bioterror       Date:  2008-12

2.  Dispensing medical countermeasures: emergency use authorities and liability protections.

Authors:  Charles G Kels
Journal:  Health Secur       Date:  2015-03-26

Review 3.  A narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy.

Authors:  Thoyaja Koritala; Akbar Hussain; Yelena Pleshkova; Lavanya Dondapati; Raghavendra Tirupathi; Ali A Rabaan; Abbas Al Mutair; Saad Alhumaid; Jaffar A Al-Tawfiq; Rahul Kashyap
Journal:  Infez Med       Date:  2021-09-10

4.  Public willingness to take a vaccine or drug under Emergency Use Authorization during the 2009 H1N1 pandemic.

Authors:  Sandra Crouse Quinn; Supriya Kumar; Vicki S Freimuth; Kelley Kidwell; Donald Musa
Journal:  Biosecur Bioterror       Date:  2009-09

Review 5.  Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.

Authors:  Vijay K Singh; Patricia L P Romaine; Thomas M Seed
Journal:  Health Phys       Date:  2015-06       Impact factor: 1.316

Review 6.  Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures.

Authors:  Vijay K Singh; Lindsay A Beattie; Thomas M Seed
Journal:  J Radiat Res       Date:  2013-05-08       Impact factor: 2.724

7.  Humanitarian access to unapproved interventions in public health emergencies of international concern.

Authors:  Jerome Amir Singh
Journal:  PLoS Med       Date:  2015-02-24       Impact factor: 11.069

Review 8.  γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.

Authors:  Vijay K Singh; Martin Hauer-Jensen
Journal:  Int J Mol Sci       Date:  2016-05-03       Impact factor: 5.923

Review 9.  The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic.

Authors:  Allan Tran; Theodore J Witek
Journal:  Pharmaceut Med       Date:  2021-08-28

Review 10.  Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents.

Authors:  Vijay K Singh; Patricia L P Romaine; Victoria L Newman; Thomas M Seed
Journal:  Expert Opin Ther Pat       Date:  2016-09-09       Impact factor: 6.674

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.